MENU
LUCD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lucid Diagnostics (LUCD) Ownership - Who owns Lucid Diagnostics?
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma... Show more
Profile
Industry
N/A
Address
360 Madison Avenue
Phone
+1 917 813-1828
Employees
70
Web
https://www.luciddx.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
42.94M
P/E Ratio
N/A
Total Cash
18.9M
Projected Growth
N/A
Total Debt
15.26M
Revenue
2.43M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.39
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price
Fundamentals
LUCD
Capitalization
42.9M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
18.9M
Total Cash/Share
0.39
Total Debt
15.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.06%
Revenue
2.43M
ROE
N/A
Book Value
-20.94M
P/B Ratio
35.09
Cash Flow
N/A
Earnings
-1.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
42K
Current Ratio
0.75
Current Revenue Per Employee
14857.14
Dividends Per Share - Security
N/A
EBITDA
-49.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
-40.10
Revenue To Assets
-176.20
Shares Held By Institutions
3.49M
Shares Outstanding - Current
48.2M
Total Liabilities
29.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
22.145
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
N/A
Address
360 Madison Avenue
Phone
+1 917 813-1828
Employees
70
Web
https://www.luciddx.com